Review
Published on 28 Nov 2012
Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2012.00258
- 8,413 views
- 13 citations
Type at least 3 characters
173 articles
Articles
Perspective
Published on 26 Nov 2012
Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2012.00273
- 8,501 views
- 24 citations
Review
Published on 22 Nov 2012
Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2012.00249
- 15,936 views
- 35 citations
Original Research
Published on 21 Nov 2012
Impact of the Interaction between 3′-UTR SNPs and microRNA on the Expression of Human Xenobiotic Metabolism Enzyme and Transporter Genes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2012.00248
- 8,308 views
- 34 citations
Opinion
Published on 16 Nov 2012
Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2012.00253
- 4,711 views
- 12 citations
Review
Published on 12 Nov 2012
MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2012.00235
- 67,677 views
- 87 citations
Original Research
Published on 05 Nov 2012
ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2012.00236
- 6,451 views
- 51 citations
Original Research
Published on 02 Nov 2012
Frequencies of 23 Functionally Significant Variant Alleles Related with Metabolism of Antineoplastic Drugs in the Chilean Population: Comparison with Caucasian and Asian Populations
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2012.00229
- 10,227 views
- 66 citations
Review
Published on 10 Oct 2012
Molecular mechanisms of genetic variation and transcriptional regulation of CYP2C19
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2012.00206
- 9,203 views
- 30 citations
Review
Published on 06 Sep 2012
Translesion DNA Polymerases and Cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2012.00174
- 23,370 views
- 55 citations
Mini Review
Published on 14 Aug 2012
Liver expression quantitative trait loci: a foundation for pharmacogenomic research
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2012.00153
- 7,280 views
- 14 citations
Original Research
Published on 08 Aug 2012
Submitted for Your Consideration: Potential Advantages of a Novel Clinical Trial Design and Initial Patient Reaction
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2012.00145
- 4,882 views
- 5 citations
Original Research
Published on 01 Sep 2011
Association of Allelic Variation in Genes Mediating Aspects of Energy Homeostasis with Weight Gain during Administration of Antipsychotic Drugs (CATIE Study)
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2011.00056
- 6,632 views
- 19 citations